Header Logo

Connection

ERICH M STURGIS to Neoplasm Recurrence, Local

Back to Details
This is a "connection" page, showing publications ERICH M STURGIS has written about Neoplasm Recurrence, Local.
ERICH M STURGIS
Connection Strength
1.150
Neoplasm Recurrence, Local
  1. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013 Jan 29; 8:21.
    View in: PubMed
    Score: 0.124
  2. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck. 2007 Aug; 29(8):731-40.
    View in: PubMed
    Score: 0.085
  3. Surviving Surveillance-Are Current Head and Neck Cancer Posttreatment Surveillance Recommendations Better for Patients or Ourselves? JAMA Otolaryngol Head Neck Surg. 2022 01 01; 148(1):51-52.
    View in: PubMed
    Score: 0.058
  4. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019 06 01; 125(11):1823-1829.
    View in: PubMed
    Score: 0.047
  5. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer? Ann Surg Oncol. 2018 Oct; 25(11):3380-3388.
    View in: PubMed
    Score: 0.045
  6. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog. 2018 03; 57(3):361-369.
    View in: PubMed
    Score: 0.043
  7. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx. Int J Cancer. 2017 10 01; 141(7):1355-1364.
    View in: PubMed
    Score: 0.042
  8. Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx. Carcinogenesis. 2017 04 01; 38(4):432-438.
    View in: PubMed
    Score: 0.042
  9. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog. 2017 04; 56(4):1335-1343.
    View in: PubMed
    Score: 0.041
  10. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer. Oncotarget. 2016 Jun 07; 7(23):34472-9.
    View in: PubMed
    Score: 0.039
  11. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Oncotarget. 2016 Jun 07; 7(23):35015-25.
    View in: PubMed
    Score: 0.039
  12. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367.
    View in: PubMed
    Score: 0.038
  13. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Int J Cancer. 2015 Nov 15; 137(10):2454-61.
    View in: PubMed
    Score: 0.037
  14. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015 Oct 01; 121(19):3455-64.
    View in: PubMed
    Score: 0.037
  15. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014 Oct 01; 120(19):3082-8.
    View in: PubMed
    Score: 0.034
  16. TNF-a promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Int J Cancer. 2014 Oct 01; 135(7):1615-24.
    View in: PubMed
    Score: 0.034
  17. Genetic variants in TNF-a promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Int J Cancer. 2014 Apr 15; 134(8):1907-15.
    View in: PubMed
    Score: 0.033
  18. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. Int J Cancer. 2013 Aug 01; 133(3):695-704.
    View in: PubMed
    Score: 0.031
  19. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 2011 May; 33(5):661-7.
    View in: PubMed
    Score: 0.027
  20. Squamous cell carcinoma of the temporal bone. Laryngoscope. 2010 Jun; 120(6):1144-51.
    View in: PubMed
    Score: 0.026
  21. Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy. Head Neck. 2010 Apr; 32(4):473-80.
    View in: PubMed
    Score: 0.026
  22. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009 Dec 15; 115(24):5723-33.
    View in: PubMed
    Score: 0.025
  23. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009 Jul 15; 115(14):3262-70.
    View in: PubMed
    Score: 0.024
  24. Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head Neck. 2009 Jan; 31(1):28-36.
    View in: PubMed
    Score: 0.023
  25. Adenoid cystic carcinoma of the external auditory canal. Laryngoscope. 2008 Sep; 118(9):1591-6.
    View in: PubMed
    Score: 0.023
  26. Outcomes of Head and Neck Microvascular Free Tissue Transfer for Advanced Cutaneous Squamous Cell Carcinoma: A Comparison of Solid Organ Transplant Recipients to Nontransplant Patients. J Oral Maxillofac Surg. 2024 Mar; 82(3):347-355.
    View in: PubMed
    Score: 0.016
  27. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. 2021 04 15; 127(8):1228-1237.
    View in: PubMed
    Score: 0.013
  28. Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes. Head Neck. 2020 11; 42(11):3326-3335.
    View in: PubMed
    Score: 0.013
  29. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Cancer. 2020 02 15; 126(4):749-756.
    View in: PubMed
    Score: 0.012
  30. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 08; 29(8):1036-1043.
    View in: PubMed
    Score: 0.012
  31. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2017 12 01; 143(12):1244-1251.
    View in: PubMed
    Score: 0.011
  32. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck. 2017 10; 39(10):2079-2087.
    View in: PubMed
    Score: 0.011
  33. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Sci Rep. 2017 01 03; 7:39765.
    View in: PubMed
    Score: 0.010
  34. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck. 2016 04; 38 Suppl 1:E1554-61.
    View in: PubMed
    Score: 0.009
  35. Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy. Carcinogenesis. 2014 Jan; 35(1):62-8.
    View in: PubMed
    Score: 0.008
  36. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck. 2008 May; 30(5):639-46.
    View in: PubMed
    Score: 0.006
  37. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.